GL1X · GenesisL1 explorer

MolNFT v1 · #136423 · protein

Structure of vaccinia virus D8 protein bound to human Fab VV304

5USL · Imv membrane protein: “Structure of vaccinia virus D8 protein bound to human Fab VV304”. X-ray diffraction, 14 pockets (best druggability 0.70). MolNFT v1 #136423 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5USL
Type
protein
Length
1,297 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Imv membrane protein; Fab VV304 heavy chain; Fab VV304 light chain
UniProt
Q1M1K6
Pockets
14 · best druggability 0.70

Structure

x-ray diffraction · 5 distinct chains · 7% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XImv membrane proteinprotein22711% helix, 37% strandQ1M1K6
AImv membrane proteinprotein22612% helix, 38% strandQ1M1K6
HFab VV304 heavy chainprotein2133% helix, 51% strand—
L, CFab VV304 light chainprotein2106% helix, 49% strand—
BFab VV304 heavy chainprotein2111% helix, 45% strand—

Pockets

14 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14630.700.8155empty
23190.680.8237empty
36080.620.7465empty
45600.610.7452empty
51470.530.8025empty

Interfaces

7 interfaces between chains.

  • H–L · 1816 Ų buried · 16 hydrogen bonds · protein-protein
  • B–C · 1801 Ų buried · 12 hydrogen bonds · protein-protein
  • A–B · 567 Ų buried · 17 hydrogen bonds · protein-protein
  • A–C · 555 Ų buried · 6 hydrogen bonds · protein-protein
  • X–H · 552 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 5USL · Structure of vaccinia virus D8 protein bound to human Fab vv304 · the same entry in another collection · chain X against X, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.